Clinical Trial Update: Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports results from the haploidentical transplantation approach studied in BMT CTN 1502 for severe aplastic anemia, with the study no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Severe Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2022-07-12